Evidence map›Paper›PMID 41178440›Full record

ArticleHaematologica2025

Elif Ince, Jaques-Emmanuel Galimard, Marianne Ifversen, Arnaud Dalissier, Zofia Szmit, Oana Mirci-Danicar, Franco Locatelli, Petr Sedlacek, Jan Styczynski, Jean-Hugues Dalle and 18 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

Elif InceAnkara University Faculty of Medicine, Department of Pediatric Hematology and BMT Unit, Ankara, Türkiye. elifunal@msn.com.
Jaques-Emmanuel GalimardEBMT Statistical Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris.
Marianne IfversenCopenhagen University Hospital Rigshospitalet, Department of Pediatric and Adolescent Medicine, Copenhagen.
Arnaud DalissierEBMT Paris Study Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP,INSERM UMRs 938, Paris.
Zofia SzmitDepartment of Pediatric Hematology/Oncology and BMT Wroclaw Medical University, Wroclaw.
Oana Mirci-DanicarBristol Royal Hospital for Children, Deptartment of Pediatric Oncology/BMT, Bristol.
Franco LocatelliDepartment of Pediatric Hematology and Oncology, IRRCS Ospedale Pediatrico Bambino Gesù, Catholic University of the Sacred Heart, Rome.
Petr SedlacekUniversity Hospital Motol, Department of Pediatric Hematology and Oncology, Prague, Czech Republic.
Jan StyczynskiUniversity Hospital, Collegium Medicum UMK, Department of Pediatric Hematology and Oncology, Bydgoszcz.
Jean-Hugues DallePediatric Hematology and Immunology Department, Robert Debre Hospital, GHU APHP Nord-Université Paris Cité, Paris.
Cecile RenardInstitut d`Hematologie et d`Oncologie Pediatrique,Unité de Coordination Interne et Externe, Lyon.
Adriana BalduzziFondazione IRCCS San Gerardo dei Tintori, Pediatric Stem Cell Transplant Unit, Monza and University of Milano-Bicocca, Department of Medicine and Surgery, Milano.
Arjan LankesterWillem-Alexander Children's Hospital, Pediatric Stem Cell Transplantation Program, Leiden University Hospital, Leiden.
Marc BieringsPrincess Maxima Center/University Hospital for Children(WKZ), Stem Cell transplantation, Utrecht.
Franca FagioliPediatric Onco-Hematology, Stem Cell Transplantation and Cell Therapy Division, Regina Margherita Children's Hospital, University of Turin, Turin.
Katrine KielsenCopenhagen University Hospital Rigshospitalet, Department of Pediatric and Adolescent Medicine, Copenhagen.
Fanny RiallandService Onco-Hématologie Pédiatrique, Hôpital Mère-Enfant, Nantes University Hospital, Nantes.
Jochen BuechnerOslo University Hospital, Department of Pediatric Hematology and Oncology, Olso.
Mervi TaskinenHospital for Children and Adolescents, Helsinki University Hospital and Helsinki University, Helsinki.
Robert WynnRoyal Manchester Children's Hospital, Department of Paediatric Hematology, Bone Marrow Unit, Manchester.
Charlotte JubertCHU Bordeaux Groupe Hospitalier Pellegrin-Enfants, Onco-Hématologie Pédiatrique, Bordeaux.
Gérard MichelHopital de la Timone, Département Hématologie Oncologie Pédiatrique, Marseille.
Herbert PichlerSt. Anna Kinderspital, Stem Cell Transplantation Unit, Vienna.
Gergely KrivanCentral Hospital of Southern Pest - National Institute of Hematology and Infectious Diseases, Deptartment for Pediatric Hematology and Hemopoietic Stem Cell Transplantation, Budapest.
Simone CesaroPediatric Hematology Oncology Unit, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, Verona.
Selim CorbaciogluDepartment of Pediatric Hematology, Oncology and Stem Cell Transplantation, University of Regensburg, Regensburg.
Roland MeiselDivision of Pediatric Stem Cell Therapy, Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, Düsseldorf.
Krzysztof KalwakDepartment of Pediatric Hematology/Oncology and BMT Wroclaw Medical University, Wroclaw.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41178440
PMCPMC12580718

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.